SHOULD 3,4-DIHYDROXY-L-PHENYLALANINE BE USED ROUTINELY IN VASCULAR PARKINSON?

SHOULD 3,4-DIHYDROXY-L-PHENYLALANINE BE USED ROUTINELY IN VASCULAR PARKINSON?

Saved in:
Bibliographic Details
Published in:Journal of the American Geriatrics Society (JAGS) Vol. 56; no. 10; pp. 1977 - 1978
Main Authors: Lauretani, Fulvio, Maggio, Marcello, Nardelli, Anna, Saccavini, Marsilio, Ceda, Gianpaolo
Format: Journal Article
Language:English
Published: Malden, USA Blackwell Publishing Inc 01-10-2008
Wiley Subscription Services, Inc
Subjects:
Aged, 80 and over
Antiparkinson Agents - therapeutic use
Humans
Levodopa - therapeutic use
Male
Parkinsonian Disorders - diagnostic imaging
Parkinsonian Disorders - drug therapy
Positron-Emission Tomography
Tomography, Emission-Computed, Single-Photon
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ArticleID:JGS1909
ark:/67375/WNG-5CJ9655B-X
istex:77F730DAC6B10CB4D36948CB4B563A350F3F7A77
ISSN:0002-8614
1532-5415
DOI:10.1111/j.1532-5415.2008.01909.x